Prohledat tento blog

09.09.12

Hereditární nádorové syndromy


  1. Přehled
  2. Indikace genetického vyšetření
  3. Seznam pracovišť lékařské genetiky
  4. Dispenzarizace dědičných nádorových syndromů
  5. Odkazy
    1. Hereditární nádorová onemocnění   Klinická onkologie, 19, 2006, Supplement, 68 - 75
    2. Klinická onkologie
    3. KOC.cz

Akreditovaná pracoviště » Moje Medicina

Akreditovaná pracoviště » Moje Medicina

Neuroendocrine Tumors: Update on Somatostatin Analogues

111In-pentetreotide scintigraphy of the 41 yea...
111In-pentetreotide scintigraphy of the 41 year-old man with ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. Radiotracer accumulation in the left thyroid in 10/2003 (arrow). The mesenterial neuroendocrine tumor became clearly visible in 4/2005 (arrow). (Photo credit: Wikipedia)
Neuroendocrine Tumors: Update on Somatostatin Analogues
Enhanced by Zemanta

Neuroendocrine Tumors: Update on Molecularly Targeted Therapies

English: Low mag. Image:Small intestine neuroe...
Neuroendocrine Tumors: Update on Molecularly Targeted Therapies
Enhanced by Zemanta

PICC and associated symptomatic upper extremity venous thrombosis

Intravenous Therapy News and Updates with IVTEAM » PICC and associated symptomatic upper extremity venous thrombosis

Persistent hiccup caused by PICC migration

Intravenous Therapy News and Updates with IVTEAM » Persistent hiccup caused by PICC migration

Incidence of migration of central line tips from the SVC to the azygous vein

Intravenous Therapy News and Updates with IVTEAM » Incidence of migration of central line tips from the SVC to the azygous vein
Enhanced by Zemanta

Risk factors: PICC related related large vein thrombosis

Intravenous Therapy News and Updates with IVTEAM » Risk factors: PICC related related large vein thrombosis
Enhanced by Zemanta

PICC and associated symptomatic upper extremity venous thrombosis

Intravenous Therapy News and Updates with IVTEAM » PICC and associated symptomatic upper extremity venous thrombosis
Enhanced by Zemanta

Research study: Valved versus open PICC occlusion rates

English: A typical peripherally inserted centr...
Intravenous Therapy News and Updates with IVTEAM » Research study: Valved versus open PICC occlusion rates
Enhanced by Zemanta

Power injectable peripherally inserted central venous catheters (PICC) flip after power injection

Chest X-ray showing tip of PICC line in the Su...
Chest X-ray showing tip of PICC line in the Superior Vena Cava (Photo credit: Wikipedia)
Intravenous Therapy News and Updates with IVTEAM » Power injectable peripherally inserted central venous catheters (PICC) flip after power injection
Enhanced by Zemanta

Reducing PICC diameter to a maximum of 5Fr is associated with a significant decrease in the rate of PICC-associated DVT

drip
Intravenous Therapy News and Updates with IVTEAM » Reducing PICC diameter to a maximum of 5Fr is associated with a significant decrease in the rate of PICC-associated DVT
Enhanced by Zemanta

PICC

A typical peripherally inserted central cathet...
A typical peripherally inserted central catheter. The maker's logo has been intentionally painted out. This is a single lumen model, but they are also available in two and three lumen models. (Photo credit: Wikipedia)
TYPY KATETRŮ



  • ARROW
  • GROSHONG
- singl či multi lumen





PÉČE

zásady: asepticky, stříkačky 10 ml

návrat krve 4-5 ml

proplach: F1/1 10 ml ( před a po aplikaci léku )

F1/1 20 ml po odběru krve

  • při proplachu používat techniku 'push-pause' - po každém ml roztoku udělat pauzu - vznikající turbulence umožní snadnější proplach a zabraňuje ucpávání katetru
  • snaha zachování pozitivního tlaku na konci katetru - při posledním aplikovaném ml zasvorkovat


zátka: HEPARINOVÁ ZÁTKA pouze pro ARROW PICC

- při opakovaném používání v průběhu dne - jen F1/1 10ml

- při používání po více jak 1 dni - heprinová zátka 5 ml s HEPARINEM 10j/ml ( delší nepoužívání katetru udává 100j/ml )



Frekvence výkonů:

- převaz krytí po zavedení za 1-3 dny - při používání 1x za 7 dnů (transparentní krytí)






Fixace katetru Stat-Lock









Odkazy:

ARROW - Peripheral catheter - Nursing care guidelines ( pdf.)





Video





Enhanced by Zemanta

AngioDynamics earns FDA clearance for BioFlo technology vascular access device to reduce catheter-related thrombus

Intravenous Therapy News and Updates with IVTEAM » AngioDynamics earns FDA clearance for BioFlo technology vascular access device to reduce catheter-related thrombus

Incidence, diagnosis, prevention and treatment of PICC related upper extremity DVT

Deutsch: B. Braun Perfusor compact, Infusionspumpe
Intravenous Therapy News and Updates with IVTEAM » Incidence, diagnosis, prevention and treatment of PICC related upper extremity DVT
Enhanced by Zemanta

The FDA have recently warned about the cardiac effect of a 32 mg single intravenous (IV) dose of ondansetron

English: Logo of the .
Intravenous Therapy News and Updates with IVTEAM » The FDA have recently warned about the cardiac effect of a 32 mg single intravenous (IV) dose of ondansetron

Doporučení k aplikaci ondansetronu:

max. 0,15 mg\/kg každé 4 hodiny max tři dávky; však žádná jednotlivá intravenózní dávka nesmí překročit 16 mg.
Enhanced by Zemanta

Comparison of catheter-related large vein thrombosis in centrally inserted versus peripherally inserted central catheters

English: Picture of my left hand and arm. Take...
Intravenous Therapy News and Updates with IVTEAM » Comparison of catheter-related large vein thrombosis in centrally inserted versus peripherally inserted central catheters

CONCLUSIONS: In neurological critical care patients, CICVCs appear to have a better risk profile compared to PICCs, with a decreased risk of CRLVT. As use of PICCs in critical care patients increases, a prospective randomized trial comparing PICCs and CICVCs in neurological critical care patients is necessary to assist in choosing the appropriate catheter and to minimize risks of morbidity and mortality associated with central venous access.
Enhanced by Zemanta

05.09.12

PICC Lines od Erin Powell na Prezi

PICC Lines od Erin Powell na Prezi

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial | DocGuide

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial | DocGuide

Subcutaneous trastuzumab, administered over about 5 min, has a pharmacokinetic profile and efficacy non-inferior to standard intravenous administration, with a similar safety profile to intravenous trastuzumab, and therefore offers a valid treatment alternative.

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes | DocGuide

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes | DocGuide


Enhanced by Zemanta

Peritoneal cancer index

Poznámky používá se k hodnocení rozsahu postižení peritoneální dutiny nádorem COLOPEC klinická studie kolorektální karcino...